BIG
TEVA icon

Brooklyn Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Brooklyn Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
56,904
+8,157
+17% +$262K 0.05% 332
2025
Q4 		$1.54M Buy
48,747
+31,902
+189% +$786K 0.07% 227
2025
Q3 		$282K Sell
16,845
-196
-1% -$3.44K 0.04% 452
2025
Q2 		$286K Buy
17,041
+12,032
+240% +$194K 0.04% 462
2025
Q1 		$77K Buy
5,009
+4,014
+403% +$71.7K 0.02% 602
2024
Q4 		$21.9K Buy
+995
New +$18.1K 0.01% 735

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brooklyn Investment Group's TEVA Position: Q1 2026 in Review

Brooklyn Investment Group increased its Teva Pharmaceuticals (TEVA) stake by 17% in Q1 2026, buying an estimated $262K and bringing the position to 56,904 shares worth $1.71M. The position accounts for 0.05% of the portfolio, ranked #332.

Brooklyn Investment Group first reported a position in TEVA in Q4 2024 and has held it in 6 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Brooklyn Investment Group held 56,904 shares of Teva Pharmaceuticals worth $1.71M as of Q1 2026.
  • Brooklyn Investment Group bought 8,157 Teva Pharmaceuticals shares in Q1 2026, an estimated $262K.
  • Teva Pharmaceuticals made up 0.05% of Brooklyn Investment Group's portfolio in Q1 2026, its #332 holding.
  • Brooklyn Investment Group first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.